Return to The AAPP Perspective issue main page.< Previous Article  Next Article >

Each year, CPNP provides 45 of your required 100 hours of BCPP Recertification credit. Don't miss out on 2020's newest releases and order today! Although course materials and examinations are not available until release dates, you can pre-register and order online today!

Psychiatric Pharmacotherapy Review Course
‚ÄčThe Psychiatric Pharmacotherapy Review Course (Released: 1/3/20; Closes: 9/30/20) is an excellent way to develop and maintain contemporary knowledge and skills at the psychiatric pharmacy specialty level.

Literature Analysis
The Literature Analysis (Released: 2/26/20; Closes: 11/30/20) product is an excellent way to maintain up-to-date knowledge on current research in the field of psychiatric pharmacy. Participants study and analyze up to 10 current pieces of literature on various topic areas.

Clinical Application Series
Through the Clinical Application Series (Released: 4/27/20; Closes: 10/27/20), you will learn from thought leaders in the field as they delve into the topics of Pain, Opioids, and Suicide, Suicide Prevention Strategies, Evaluation and Treatment of Impulsivity and Aggression, Treatment of HIV-Associated Neurocognitive Disorder, and Long-Acting Injectable Antipsychotics.

From Theory to Practice Case Series
From Theory to Practice Case Series (Releases: 9/28/20; Closes 3/25/21) provides the opportunity to study a complex psychiatric case comorbid with a medical diagnosis and associated complex medication regimen. A patient is followed over three encounters with each one consisting of a case study, pre-recorded webinar, and self-assessment questions. This edition is geriatric-focused, and the three encounters include delirium, dementia, and behavioral and psychological symptoms of dementia (BPSD). In the first encounter, the case explores a patient who has developed delirium during a hospitalization from both predisposing and precipitating factors (i.e., acute medical illness, anticholinergic use, sedative/hypnotic withdrawal). The webinar reviews diagnostic criteria, precipitating and predisposing factors, and a summary of guideline recommendations on the prevention and treatment of delirium. In the second encounter, the patient case focuses on dementia onset and adverse effects from cholinesterase inhibitors (e.g., bradycardia, urinary incontinence). The webinar reviews major neurocognitive disorder due to Alzheimer’s disease diagnostic criteria, treatment guidelines, an overview of cholinesterase inhibitors and memantine, and highlights important medication trials from the past several years. Lastly, the third case encounter finds the patient experiencing BPSD. The webinar reviews treatment guidelines, nonpharmacologic strategies, and pharmacologic treatment options and risks for BPSD. Given this geriatric focus, CPNP is working with ASCP to provide 5 hours of Board Certified Geriatric Pharmacy (BCGP) credit for this product in addition to BCPP credit provided by CPNP.

Psychopharmacology Pearls
Psychopharmacology Pearls (Releases: 11/6/20; Closes 5/5/21) consists of four clinical review articles focused on single disorders, or on one or more distinct aspects of a single psychiatric, neurologic, or substance use disorder. These case-based articles will offer therapeutic advice based on both evidence and longstanding clinical experience. Topics include alcohol and opioid detoxification in the ambulatory care setting, generalized anxiety disorder, mood disorders and traumatic brain injury, and seizures and new antiepileptic medications.


Return to The AAPP Perspective issue main page.< Previous Article  Next Article >